scholarly journals Free erythrocyte porphyrin: hemoglobin ratios, serum ferritin, and transferrin saturation levels during treatment of infants with iron- deficiency anemia

Blood ◽  
1977 ◽  
Vol 49 (3) ◽  
pp. 455-462
Author(s):  
WJ Thomas ◽  
HM Koenig ◽  
AL Jr Lightsey ◽  
R Green

Free erythrocyte porphyrin:hemoglobin (FEP:Hb) ratios were determined on 20 infants with iron-deficiency anemia. FEB:Hb ratios were compared with simultaneously drawn serum ferritin and serum transferrin saturation levels. FEP:Hb ratios dropped steadily during treatment of the anemic infants, but remained elevated compared to age-matched nonanemic infants, until the anemia was corrected. FEP:Hb ratios detected iron deficiency when acute inflammatory disease was present. Serum ferritin levels and transferrin saturation failed to detect iron deficiency after iron therapy was started or when acute inflammatory disease was present. Measurement of FEP:Hb ratios is a reliable and practical way to make a prompt diagnosis of iron-deficiency anemia in infants.

Blood ◽  
1977 ◽  
Vol 49 (3) ◽  
pp. 455-462 ◽  
Author(s):  
WJ Thomas ◽  
HM Koenig ◽  
AL Jr Lightsey ◽  
R Green

Abstract Free erythrocyte porphyrin:hemoglobin (FEP:Hb) ratios were determined on 20 infants with iron-deficiency anemia. FEB:Hb ratios were compared with simultaneously drawn serum ferritin and serum transferrin saturation levels. FEP:Hb ratios dropped steadily during treatment of the anemic infants, but remained elevated compared to age-matched nonanemic infants, until the anemia was corrected. FEP:Hb ratios detected iron deficiency when acute inflammatory disease was present. Serum ferritin levels and transferrin saturation failed to detect iron deficiency after iron therapy was started or when acute inflammatory disease was present. Measurement of FEP:Hb ratios is a reliable and practical way to make a prompt diagnosis of iron-deficiency anemia in infants.


Blood ◽  
1981 ◽  
Vol 58 (5) ◽  
pp. 963-968 ◽  
Author(s):  
E Vichinsky ◽  
K Kleman ◽  
S Embury ◽  
B Lubin

Abstract We determined the prevalence and optimal methods for laboratory diagnosis of iron deficiency anemia in patients with sickle cell disease. Laboratory investigations of 38 nontransfused and 32 transfused patients included transferrin saturation, serum ferritin, mean corpuscular volume (MCV), and free erythrocyte protoporphyrin (FEP). Response to iron supplementation confirmed the diagnosis of iron deficiency anemia in 16% of the nontransfused patients. None of the transfused patients were iron deficient. All iron-deficient patients (mean age 2.4 yr) had a low MCV, serum ferritin less than 25 ng/ml, transferrin saturation less than 15%, and FEP less than 90 micrograms/dl RBC. Following therapy, all parameters improved and the hemoglobin concentration increased greater than 2 g/dl. A serum ferritin below 25 ng/ml was the most reliable screening test for iron deficiency. There were 13% false positive results with transferrin saturation, 3% with MCV, and 62% with FEP. FEP values correlated strongly with reticulocyte counts. The high FEP was in part due to protoporphyrin IX and not completely due to zinc protoporphyrin, which is elevated in iron deficiency. We conclude that iron deficiency anemia is a potential problem in young nontransfused sickle cell patients. Serum ferritin below 25 ng/ml and low MCV are the most useful screening tests.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 4897-4897
Author(s):  
Hassan A. Al-Jafar ◽  
S Al-Fadhli ◽  
Althallab F ◽  
Mubark Al Ageeli

Abstract Hypoferritinemia Without Anemia The Possible Diagnostic Thought Hassan Al-Jafar , Saud Al-Fadli , Fatma Al-Thelab , Mubark Al-Aqeel Introduction : Iron metabolism still an active area in research work which provide more knowledge of aetiology and pathogenesis of the diseases and provide new treatment methods based on the new research results . HWA is one of the metabolic disorders where all the investigations are withen normal reference ranges . HWA patients could have long standing complain , while few HWA patients have no complains . The normal all results make HWA a hidden disease with lack in the exact underling cause . Iron deficiency anemia ( IDA ) and latent iron deficiency anemia ( LIDA ) are easy to diagnose from the clinical and the laboratory results , where IDA has anemia and LIDA has at least one paremeter in complete blood count that indicate a stage of pre-iron deficiency anemia . HWA desease has normal results except low ferritin level , ehat make pre-pre-IDA or pre-LIDA with normal transferrin saturation a stutus which was not described before . In the letreture serum ferritin found to be low in canins due to autoantibodies , also there could be another factors which not yet known that may affect iron metabolism and causing HWA . Aim: This research project is looking for interpretation for HWA to treat it by methods other than iron or iron infusion as many unpleasant and side effects accompanied both oral and intravenous iron treatment. Methodology and tools: From our hospital data and from the outpatient department 75 Patients 36 male and 39 females were reviewed to detect the variations of complete blood count parameters in comparison with iron status. Tools: Complete blood count (CBC), HPLC, serum iron, serum ferritin, transferrin. Including criteria: Adult male and female patients, normal HPLC results. Excluding criteria: Abnormal HPLC, Family history of hemoglobinopathy disorders for patients investigated prospectively, patients on iron treatment excluded from this study. Results: In IDA group usually all the parameters indicate IDA. In LIDA group at least one parameter or more indicate iron deficiency. In HWA group only, ferritin is low and transferrin saturation is normal while it is expected to be low if HWA underling aetiology is iron deficiency. Table [ 1] Conclusion: IDA and LIDA are easly diagnosed , while HWA has only low serum ferritin which is not routinely done. In HWA the results are not going with the usual parameters of iron metabolism and homeostasis, when low ferritin found with normal transferrin saturation in the same sampling days. HWA could be just an early pre- LIDA or may be a low ferritin reference range in some countries especially when the patient has no complains, or the body could have another unknow storage mechanisms other than ferritin. HWA also might be hormonal deficiency which reduce acute reactive proteins which could affect serum ferritin level or HWA could be an antibody against ferritin which has no influence on serum iron, but it renders serum ferritin lower than normal. HWA is important from many aspects , first it is a hidden disorder which need to be known by the physicians for diagnosis and treatment and it is important from academic point of view to answer to its indecisive aetiology and pathogenesis especially when it has a controversy in low ferritin and normal transferrin saturation . Adding more research tools as hepcidin test could provide more information to understand HWA disorder better. References: 1-Wei Wang , Mary Knovich , Lan G.Coffman Frank M, Torti , Suzy V. Torti , Serum ferritin :Past , Present and future Biochim Biophys acta , 2010 August ; 1800 (8) : 760-769 2-Hassan Al-Jafar, HWA: Hypoferritinemia without a hidden hematology disorder, journal of family medicine and primary care 2017, volume: 6, issue: 1 p 69-72 Disclosures No relevant conflicts of interest to declare.


2018 ◽  
Vol 5 (2) ◽  
pp. 499
Author(s):  
Kanchana . ◽  
Madhusudan Sr. ◽  
Sam Ahuja ◽  
Niranjan Nagaraj

Background: Anemia is a global public health problem affecting both developing and developed countries with major consequences for human health as well as social and economic development. This study is conducted to assess the proportion of children, aged between 6 months to 5 years having anemia and risk factors of iron deficiency anemia among selected children with anemia. Methods: The present cross-sectional study was conducted in 500 children between the age of 6 months to 5 years, who were admitted (in patients) to the Department of Pediatrics of Dr. BR Ambedkar Medical College, Bangalore, were selected and screened for anemia by hemoglobin estimation. This study was carried out from November 2012 to April 2014. Among those children with hemoglobin <11 g/dl, were screened for iron deficiency anemia (Serum ferritin estimation is done). Among these 500 children, 100 children with a hemoglobin level of 11 gm/dl and serum ferritin <12 μg/L were taken up for detailed study. All the collected data was tabulated and statically analysed by using appropriate methods Results: 77.8% of screened children were found to have anemia. In studied children 38% had mild anemia, 54% had moderate anemia and 8% had severe anemia. Male outnumbered than female in the ratio of 1.17:1. More than 50% presented with acute gastroenteritis.79% of anemic children had malnutrition. 24% of anemic children were low birth weight. Dimorphic anemia was common in 6months to 5 years age group. Mean hemoglobin level was 9.26. Mean ferritin, mean serum iron, TIBC, transferrin saturation was 7.23 μg/l, 52.60μg/dl, 346.89mg/dl and 16.31% respectively Conclusions: The diet deficient in iron and other essential nutrients is the single most important cause of anemia in children of this age Diarrhea was the chief associated symptom in more than half the cases studied. Hence it is essential to make provision for safe drinking water and to improve sanitary facilities periodic deworming measure is advised, to reduce parasitic infestation which also contributes to the development of anemia.


Blood ◽  
1981 ◽  
Vol 58 (5) ◽  
pp. 963-968 ◽  
Author(s):  
E Vichinsky ◽  
K Kleman ◽  
S Embury ◽  
B Lubin

We determined the prevalence and optimal methods for laboratory diagnosis of iron deficiency anemia in patients with sickle cell disease. Laboratory investigations of 38 nontransfused and 32 transfused patients included transferrin saturation, serum ferritin, mean corpuscular volume (MCV), and free erythrocyte protoporphyrin (FEP). Response to iron supplementation confirmed the diagnosis of iron deficiency anemia in 16% of the nontransfused patients. None of the transfused patients were iron deficient. All iron-deficient patients (mean age 2.4 yr) had a low MCV, serum ferritin less than 25 ng/ml, transferrin saturation less than 15%, and FEP less than 90 micrograms/dl RBC. Following therapy, all parameters improved and the hemoglobin concentration increased greater than 2 g/dl. A serum ferritin below 25 ng/ml was the most reliable screening test for iron deficiency. There were 13% false positive results with transferrin saturation, 3% with MCV, and 62% with FEP. FEP values correlated strongly with reticulocyte counts. The high FEP was in part due to protoporphyrin IX and not completely due to zinc protoporphyrin, which is elevated in iron deficiency. We conclude that iron deficiency anemia is a potential problem in young nontransfused sickle cell patients. Serum ferritin below 25 ng/ml and low MCV are the most useful screening tests.


Author(s):  
Sajjad H. Naqvi ◽  
Syed Faizan-ul-Hassan Naqvi ◽  
Iftikhar H. Naqvi ◽  
Muhammad Farhan ◽  
Tanveer Abbas ◽  
...  

2021 ◽  
Vol 11 (01) ◽  
pp. e199-e204
Author(s):  
Osama Mahmoud El-Asheer ◽  
Ahmed Gaber Ahmed ◽  
Zainab AbdelAal Abdel Hafez ◽  
Marwa AbdelHafiz Dahpy ◽  
Amal AbdElSalam Soliman

AbstractLactoferrin (LF) is an iron-binding globular glycoprotein that is structurally and chemically similar to serum transferrin. Many studies have been done to evaluate the effect of oral LF administration on iron deficiency anemia (IDA) with controversial results. This study was designed to compare the efficacy of LF versus oral ferrous sulfate (OFS) therapy in the treatment of children with IDA. A significant increase in mean hemoglobin and serum iron concentrations was noted in the group that received oral bovine LF (11.06 ± 0.96 and 42.79 ± 6.14, respectively) versus the group that received OFS (10.24 ± 0.57 and 28.94 ± 5.05, respectively, with p < 0.001 for each) after 30 days of the treatment with fewer side effects (9.3 vs. 33.3% with p = 0.043). Oral bovine LF is a more effective and safer alternative in treating iron deficiency and IDA compared with OFS with clinical benefits of fewer side effects and better patient compliance.


Sign in / Sign up

Export Citation Format

Share Document